These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5312135)

  • 1. [At the begining of the 22d therapy-week. A press conference on a new antirheumatic agent].
    Med Monatsschr; 1970 Oct; 24(10):433-4. PubMed ID: 5312135
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems in symptomatic therapy of rheumatic diseases with glucocorticoids and nonsteroidal antirheumatic agents].
    Mathies H
    Internist (Berl); 1979 Sep; 20(9):414-25. PubMed ID: 387649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].
    Fiegel G
    Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254
    [No Abstract]   [Full Text] [Related]  

  • 4. [On clinical evaluation of the effect of azapropazon, a new anti-inflammatory agent, in diseases of the rheumatic group].
    Beckschäfer W
    Arzneimittelforschung; 1969 Jan; 19(1):52-3. PubMed ID: 4182977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Roundtable conference: "Interactions of anti-rheumatic drugs"].
    Jesserer H; Estler CJ; Gugler R; Hattingberg HM; Kahl GF; Kaiser H; Karzel K; Kewitz H; Klein G; Schattenkirchner M; Schönhöfer PS
    Verh Dtsch Ges Rheumatol; 1978; 5():283-7. PubMed ID: 309237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of rheumatic disease using a new antirheumatic drug].
    Weigel H
    Z Allgemeinmed; 1974 Nov; 50(33):1527-31. PubMed ID: 4549149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Photobadismographic demonstration of azapropazone].
    Ulrych JI; Olbrich E; Sausgruber H
    Z Rheumaforsch; 1973; 32(3):133-5. PubMed ID: 4540946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy of rheumatic diseases during pregnancy.
    Soscia PN; Zurier RB
    Bull Rheum Dis; 1992; 41(2):1-3. PubMed ID: 1600444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research on the antirheumatic action of a new nonsteroid antiphlogistic drug, butoxyphenyl-acethydroxamic acid].
    Spotorno N; Viara M
    Reumatismo; 1968; 20(2):172-5. PubMed ID: 5311717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical efficacy of the new anti-inflammatory agent Azapropazone].
    Sausgruber H
    Arzneimittelforschung; 1971 Aug; 21(8):1230-4. PubMed ID: 4938489
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic efficacy of a new antirheumatic agent with optimal gastrointestinal tolerance: 2-phenyl-4,p-chlorophenyl-thiazol-5-ilacetic acid (Fentiazac)].
    Gorini M; Chizzi A; Dal Ri P; De Caro L
    Reumatismo; 1976; 28(1):15-29. PubMed ID: 1088315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current developments in antirheumatic medication. II. Metabolic and cartilage-protective medication].
    Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(3):193-208. PubMed ID: 2573929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antirheumatic drug therapy 1986: further uncertainty and new hope].
    Krüger K
    Fortschr Med; 1987 Jan; 105(1):1-3. PubMed ID: 3493956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a new antirheumatic drug: midalgyl].
    Vignon G; Laurent J; Kopp N
    Presse Med (1893); 1970 Nov; 78(48):2145-6. PubMed ID: 5312370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical testing of a new anti-inflammatory agent].
    Malerba F; Barbi GL
    Clin Ter; 1969 Apr; 49(1):63-7. PubMed ID: 4930402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antirheumatic therapy with new non-steroidal compounds (author's transl)].
    Fenner H
    MMW Munch Med Wochenschr; 1981 Sep; 123(37):1377-82. PubMed ID: 6793854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid therapy in the course of time].
    Kaiser H; Burmester GR; Buttgereit F
    Z Rheumatol; 2005 Apr; 64(3):147-8. PubMed ID: 15868330
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent.
    Branco do Amaral A
    Pharmatherapeutica; 1982; 3(3):174-9. PubMed ID: 6982478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current anti-rheumatism agents].
    Tsvetkova ES
    Med Sestra; 1978 Jan; 37(1):17-9. PubMed ID: 306018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.